{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:11:48Z","timestamp":1794852708933,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006706","name":"Tampere Tuberculosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115910"],"award-info":[{"award-number":["115910"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126573","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:47:05Z","timestamp":1732924025000},"page":"126573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Association of baseline cytokines with antibody concentrations after diphtheria-tetanus-acellular pertussis booster vaccination in Finnish children"],"prefix":"10.1016","volume":"44","author":[{"given":"Denise","family":"Anabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna T.","family":"Ter\u00e4sj\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex-Mikael","family":"Barkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aapo","family":"Knuutila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"van Gageldonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Buisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Mertsola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126573_bb0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/apm.13165","article-title":"Pertussis seroprevalence among adults of reproductive age (20\u201339 years) in fourteen European countries","volume":"129","author":"Wehlin","year":"2021","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2024.126573_bb0010","first-page":"12","article-title":"Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries","author":"Berbers","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126573_bb0015","first-page":"32","article-title":"Factors that influence the immune response to vaccination","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.126573_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","article-title":"Primary vaccine failure to routine vaccines: why and what to do?","volume":"12","author":"Wiedermann","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126573_bb0025","first-page":"65","article-title":"Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: a collaborative study in Finland, the Netherlands, and the United Kingdom","author":"Versteegen","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2024.126573_bb0030","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1080\/22221751.2022.2053364","article-title":"Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups","volume":"11","author":"Knuutila","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.126573_bb0035","first-page":"13","article-title":"Memory B cell activation induced by pertussis booster vaccination in four age groups of three countries","author":"Versteegen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0040","first-page":"70","article-title":"Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS","author":"Nehar-Belaid","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.it.2020.04.001","article-title":"Improving vaccine-induced immunity: can baseline predict outcome?","volume":"41","author":"Tsang","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0050","first-page":"12","article-title":"Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants. Emerg","author":"Knuutila","year":"2023","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.126573_bb0055","first-page":"9","article-title":"Vaccine-induced cellular immunity against bordetella pertussis: harnessing lessons from animal and human studies to improve design and testing of novel pertussis vaccines","author":"Saso","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126573_bb0060","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.153.11.4948","article-title":"Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2","volume":"153","author":"Kawano","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cyto.2015.02.007","article-title":"B cells responses and cytokine production are regulated by their immune microenvironment","volume":"74","author":"Vazquez","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2024.126573_bb0070","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4049\/jimmunol.159.3.1150","article-title":"The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice","volume":"159","author":"Johnson-Lcger","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.126573_bb0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0264-410X(89)90162-X","article-title":"Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults","volume":"7","author":"St\u00fcrchler","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126573_bb0085","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","article-title":"IL-5- and eosinophil-mediated inflammation: from discovery to therapy","volume":"21","author":"Kouro","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ics.2005.07.094","article-title":"Role of IL-5 in the innate immune system and disease control","volume":"1285","author":"Takatsu","year":"2005","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.vaccine.2024.126573_bb0095","volume":"90","author":"Punnonen","year":"1993","journal-title":"Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells (B-cell differentiation\/isotype switching\/allergy)"},{"key":"10.1016\/j.vaccine.2024.126573_bb0100","series-title":"De Vries2 JE. IL-13 Induces Proliferation, Ig lsotype Switching, and Ig Synthesis by Immature Human Fetal B Cells","author":"Punnonen","year":"1994"},{"key":"10.1016\/j.vaccine.2024.126573_bb0105","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.126573_bb0110","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/acs.jproteome.5b00258","article-title":"Immunoproteomic profiling of Bordetella pertussis outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity","volume":"14","author":"Raeven","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.vaccine.2024.126573_bb0115","first-page":"10","article-title":"Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines","author":"Esposito","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0120","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.4049\/jimmunol.1502641","article-title":"IL-17 augments B cell activation in ocular surface autoimmunity","volume":"197","author":"Subbarayal","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1189\/jlb.1VMR0216-096RR","article-title":"IL-17 superfamily cytokines modulate normal germinal center B cell migration","volume":"100","author":"Ferretti","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0130","author":"Avey","year":"2017","journal-title":"Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses"},{"key":"10.1016\/j.vaccine.2024.126573_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108515","article-title":"The IL-2 \u2013 IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor","volume":"218","author":"Damoiseaux","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0140","first-page":"217","article-title":"Biology and therapeutic potential of interleukin-10","author":"Saraiva","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.126573_bb0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation","volume":"36","author":"Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2024.126573_bb0150","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1126\/sciimmunol.aaw7636","article-title":"Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells","volume":"4","author":"Papillion","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012557","article-title":"MIG and the regulatory cytokines IL-10 and TGF-\u03b21 correlate with malaria vaccine immunogenicity and efficacy","volume":"5","author":"Dunachie","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126573_bb0160","first-page":"6","article-title":"Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics","author":"Hendrikx","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126573_bb0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imm.13012","article-title":"Systems vaccinology and big data in the vaccine development chain","volume":"156","author":"Raeven","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2024.126573_bb0170","doi-asserted-by":"crossref","first-page":"17842","DOI":"10.1038\/s41598-017-17865-2","article-title":"Cytokine profiling in healthy children shows association of age with cytokine concentrations","volume":"7","author":"Decker","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.126573_bb0175","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126573_bb0180","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10964-019-01101-3","article-title":"Pubertal status and age are differentially associated with inflammatory biomarkers in female and male adolescents","volume":"49","author":"Stumper","year":"2020","journal-title":"J Youth Adolesc"},{"key":"10.1016\/j.vaccine.2024.126573_bb0185","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s41590-022-01329-5","article-title":"Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination","volume":"23","author":"Fourati","year":"2022","journal-title":"Nat Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:48:16Z","timestamp":1735656496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24012556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":37,"alternative-id":["S0264410X24012556"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126573","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of baseline cytokines with antibody concentrations after diphtheria-tetanus-acellular pertussis booster vaccination in Finnish children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126573"}}